Cargando…

Real-world Early Outcomes and Retreatment Rates Following Water Vapour Ablative Therapy for Symptomatic Benign Prostatic Hyperplasia

BACKGROUND: Rezūm water vapour ablation is an effective minimally invasive surgical therapy for the treatment of bladder outflow obstruction. OBJECTIVE: To present early outcomes and reoperation rates after Rezūm, including an analysis of retreatment rates to gain an insight into optimal patient sel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whiting, Danielle, Noureldin, Mohamed, Abdelmotagly, Yehia, Johnston, Maximilian J., Brittain, James, Rajkumar, Govindaraj, Emara, Amr, Hindley, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Benign Prostatic Enlargement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068731/ https://www.ncbi.nlm.nih.gov/pubmed/35528787 http://dx.doi.org/10.1016/j.euros.2022.03.006

Ejemplares similares

Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer
por: Glaser, Alexander, et al.
Publicado: (2022)

Oral desmopressin in nocturia with benign prostatic hyperplasia: A systematic review of the literature
por: Taha, Diaa-Eldin, et al.
Publicado: (2018)

Transperineal intraprostatic injection of botulinum neurotoxin A vs transurethral resection of prostate for management of lower urinary tract symptoms secondary to benign prostate hyperplasia: A prospective randomised study
por: El-Dakhakhny, Amr S., et al.
Publicado: (2019)

The role of Rezum in the management of refractory urinary retention due to benign prostate hyperplasia: A literature review
por: Khalil, Ibrahim A., et al.
Publicado: (2023)

Simultaneous antegrade and retrograde endoscopic surgery for benign prostatic hyperplasia with vesical calculi – A single-centre experience
por: Javali, Tarun, et al.
Publicado: (2018)

Greenlight laser (XPS(TM)) 180W prostatectomy for treatment of benign prostate hyperplasia in patients with uncorrectable bleeding tendency
por: Elshal, Ahmed M., et al.
Publicado: (2022)

WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30–80-cm(3) and 80–150-cm(3) Prostates
por: Nguyen, David-Dan, et al.
Publicado: (2021)

Newer Minimally Invasive Treatment Modalities to Treat Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia
por: Dahm, Philipp, et al.
Publicado: (2021)

New Ultra-minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia: A Systematic Review and Analysis of Comparative Outcomes
por: Checcucci, Enrico, et al.
Publicado: (2021)

A Systematic Review and Meta-analysis of Prostatic Urethral Lift for Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
por: Xiang, Peng, et al.
Publicado: (2020)

‘Top-Down’ holmium laser enucleation of the prostate. Report of initial cases performed by a single surgeon
por: Hodhod, Amr, et al.
Publicado: (2020)

Thulium laser enucleation of the prostate (ThuLEP): Results, complications, and risk factors in 139 consecutive cases
por: Raber, Marco, et al.
Publicado: (2018)

Minimally invasive simple prostatectomy in the era of laser enucleation for high-volume prostates: A systematic review and meta-analysis
por: Abi Chebel, Josselin, et al.
Publicado: (2020)

Updated strategies in the treatment of benign diseases—a patterns of care study of the german cooperative group on benign diseases
por: Kriz, Jan, et al.
Publicado: (2018)

Systematic Review and Meta-analysis of Candidate Gene Association Studies of Lower Urinary Tract Symptoms in Men [Image: see text] ()
por: Cartwright, Rufus, et al.
Publicado: (2014)

Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
por: Cai, Tong, et al.
Publicado: (2020)

Global, Regional, and National Incidence and Year Lived with Disability for Benign Prostatic Hyperplasia from 1990 to 2019
por: Xu, Xiao-Feng, et al.
Publicado: (2021)

The Efficacy and Safety of HoLEP for Benign Prostatic Hyperplasia With Large Volume: A Systematic Review and Meta-Analysis
por: Sun, Fengze, et al.
Publicado: (2022)

Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: Is there a possible relationship?
por: Agamia, Naglaa F., et al.
Publicado: (2016)

Prostatic Artery Embolization for Benign Prostatic Hyperplasia Treatment: A Russian Multicenter Study in More Than 1,000 Treated Patients
por: Kamalov, Armais, et al.
Publicado: (2020)

Meta-Analysis of Efficacy and Safety of Tadalafil Plus Tamsulosin Compared with Tadalafil Alone in Treating Men with Benign Prostatic Hyperplasia and Erectile Dysfunction
por: Zhou, Zhongbao, et al.
Publicado: (2019)

Day care bipolar transurethral resection vs photoselective vaporisation under sedoanalgesia: A prospective, randomised study of the management of benign prostatic hyperplasia
por: Sood, Rajeev, et al.
Publicado: (2017)

Body Mass Index and Risk of Prostate Volume, International Prostate Symptom Score, Maximum Urinary Flow Rate, and Post-Void Residual in Benign Prostatic Hyperplasia Patients
por: Li, Bing-Hui, et al.
Publicado: (2019)

Is Serenoa repens Effective in the Treatment of Benign Prostatic Hyperplasia?
por: Çeker, Gökhan
Publicado: (2020)

The Efficacy and Safety of Holmium Laser Enucleation of Prostate Compared With Bipolar Technologies in Treating Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials
por: Che, Xuanyan, et al.
Publicado: (2022)

Efficacy and Safety of Combination Comprising Tamsulosin and PDE5-Is, Relative to Monotherapies, in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction Associated With Benign Prostatic Hyperplasia: A Meta-Analysis
por: Chai, Yumeng, et al.
Publicado: (2021)

Cochlea-sparing acoustic neuroma treatment with 4π radiation therapy
por: Woods, Kaley, et al.
Publicado: (2018)

Superficial radiation therapy in peyronie’s disease: An effective and well-tolerated therapy
por: Pietsch, Gunilla, et al.
Publicado: (2018)

Goserelin acetate before transurethral resection of moderately enlarged benign prostatic hyperplasia: Prospective randomised-controlled clinical trial
por: Abo El-Enen, Mohamed, et al.
Publicado: (2016)

Population‐based study of long‐term functional outcomes after prostate cancer treatment
por: Carlsson, Sigrid, et al.
Publicado: (2015)

Emerging Data on the Safety and Efficacy of Transurethral Water Vapour Therapy for Benign Prostatic Hyperplasia
por: Jones, Patrick, et al.
Publicado: (2021)

Focal Therapy: Patients, Interventions, and Outcomes—A Report from a Consensus Meeting
por: Donaldson, Ian A., et al.
Publicado: (2015)

Transurethral ethanol ablation for symptomatic benign prostatic hyperplasia
por: Gautam, Gagan, et al.
Publicado: (2007)

The efficacy of balloon dilation in achalasia is the result of stretching of the lower esophageal sphincter, not muscular disruption
por: Borhan‐Manesh, F., et al.
Publicado: (2015)

Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED
por: Sebastianelli, A., et al.
Publicado: (2020)

Evaluation of intermittent tamsulosin in treating symptomatic patients with benign prostatic hyperplasia
por: Soliman, Mohamed G., et al.
Publicado: (2023)

Early experience in MRI-guided therapies of prostate cancer: HIFU, laser and photodynamic treatment
por: Da Rosa, M.R., et al.
Publicado: (2011)

Developing a class solution for Prostate Stereotactic Ablative Body Radiotherapy (SABR) using Volumetric Modulated Arc Therapy (VMAT)
por: Murray, Louise J., et al.
Publicado: (2014)

Prostate Cancer Risk Inflation as a Consequence of Image-targeted Biopsy of the Prostate: A Computer Simulation Study
por: Robertson, Nicola L., et al.
Publicado: (2014)

PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate
por: Ferraldeschi, Roberta, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7ekdhaoirf9r9ncjr2udme2sgr